Rechter.
Blue cell-like structures, pink clusters, and orange particles in a three-dimensional scientific illustration.

TriaCyte

Seed round

CAR-T therapy has transformed treatment for some blood cancers. Solid tumors pose another challenge: reaching them, getting inside, and staying active. An AI-designed navigation system could help these therapies cross that barrier.

I worked with the founder throughout the seed round to build a coherent investment case.

TriaCyte develops AI-engineered receptors to help therapeutic immune cells locate and infiltrate solid tumors.

Illustrated comparison of blood cancers, labeled 7%, and solid tumors, labeled 93%.
Cell therapy mission diagram linking a blue cell and its receptor to a pink solid tumor.
Receptor morphology illustration showing the cell interior, cell environment, and an orange molecular cluster.
Storyboard organizing the presentation into cell therapy potential, opportunity, mechanism, and seed-stage plan.